Abstract: Disclosed herein are viral vectors for use in recombinant molecular biology techniques. In particular, the present disclosure relates to self-limiting viral vectors comprising genes encoding site-specific endonucleases as well as recognition sequences for site-specific endonucleases such that expression of the endonuclease in a cell cleaves the viral vector and limits its persistence time. In some embodiments, the viral vectors disclosed herein also carry directives to delete, insert, or change a target sequence.
Type:
Application
Filed:
November 22, 2022
Publication date:
June 22, 2023
Applicant:
Precision BioSciencens, Inc.
Inventors:
Derek Jantz, James Jefferson Smith, Michael G. Nicholson